The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Frequent overexpression of NECTIN-4 in CNS metastases from urothelial carcinoma.
 
Richard Weiten
No Relationships to Disclose
 
Constantin Rieger
No Relationships to Disclose
 
Melanie von Brandenstein
No Relationships to Disclose
 
Enno Storz
No Relationships to Disclose
 
Yuri Tolkach
No Relationships to Disclose
 
Thomas Stehle
No Relationships to Disclose
 
Teresa Schmidt
No Relationships to Disclose
 
Martin Glas
Honoraria - Bayer; Kyowa Kirin; Medac; Merck; Novartis; Novocure
Consulting or Advisory Role - Abbvie; Daiichi Sankyo; Novartis; Novocure; Roche
Travel, Accommodations, Expenses - Medac; Novocure
 
Tobias Blau
No Relationships to Disclose
 
Kathy Keyvani
No Relationships to Disclose
 
Viktor Grünwald
Employment - University Hospital Essen
Stock and Other Ownership Interests - AstraZeneca; Bicycle Therapeutics; Bristol-Myers Squibb; Genmab; MSD
Honoraria - Advanced Accelerator Applications/Novartis; Amgen; Apogepha; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eisai; Ipsen; Janssen-Cilag; Merck Serono; MSD Oncology; Ono Pharmaceutical; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Cureteq; Debiopharm Group; Eisai; Gilead Sciences; Ipsen; Janssen-Cilag; MSD Oncology; Novartis; Oncorena; PCI Biotech; Pfizer; Synthekine
Research Funding - Amgen (Inst); Bicycle Therapeutics (Inst); BMS (Inst); Gilead Sciences (Inst); Ipsen (Inst); MSD Oncology (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Janssen; Merck Serono; Pfizer
 
Michael Hölzel
Stock and Other Ownership Interests - Bicycle Therapeutics; Daiichi Sankyo/UCB Japan; immatics
Honoraria - Biotex/Oncomagnetix; Bristol-Myers Squibb/Roche; Novartis; TME Pharma
Consulting or Advisory Role - BioTex / Oncomagnetics; Novartis; TME Pharma
Research Funding - TME Pharma
Patents, Royalties, Other Intellectual Property - EP 23 000 076.2 and EP 23 000 075.4 patent applications related to biomarkers for NOX-A12 therapy.
Travel, Accommodations, Expenses - TME Pharma
 
Axel Heidenreich
Honoraria - Amgen; Astellas Pharma; Bayer; Ferring; Ipsen; Janssen-Cilag; Sanofi; Takeda
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; BMS Global; Clovis Oncology; Janssen-Cilag; MSD Oncology
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; Ipsen; Johnson & Johnson; Pfizer; Sanofi; Takeda
Research Funding - BMS Oncology
 
Markus Eckstein
Employment - Diaceutics
Honoraria - Astellas Pharma; AstraZeneca; Diaceutics; Genomic Health; Janssen-Cilag; Owkin; Roche
Consulting or Advisory Role - AstraZeneca; Diaceutics; Genomic Health; Gilead Sciences; Janssen-Cilag; MSD Oncology; Owkin
Speakers' Bureau - Astellas Pharma; AstraZeneca; Diaceutics; MSD; Roche
Research Funding - AstraZeneca/MedImmune; AstraZeneca/MedImmune; Gilead Sciences; Janssen; Owkin; STRATIFYER Molecular Pathology
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Diaceutics; Genomic Health; Janssen-Cilag; MSD; Roche
 
Niklas Klümper
Stock and Other Ownership Interests - Bicycle Therapeutics; Daiichi Sankyo/UCB Japan; immatics; Pfizer
Honoraria - Astellas Pharma; MSD Oncology
Consulting or Advisory Role - Astellas Pharma; Eisai; MSD Oncology
Travel, Accommodations, Expenses - Ipsen; MSD Oncology; Photocure